New cancer pill gives hope and strategy

Published: 2012-03-28 06:58:00

Updated: 2012-03-28 06:58:00

Pfizer Korea’s just-launched drug Xalkori (crizotinib), the first new medicine for deadly lung cancer, proves the value of precisely targeting rare diseases linked to gene variants, cancer specialists said.

Pfizer Korea held a news briefing Friday to discuss the implications of the new drug.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK